Optic pathway glioma
Active Research Protocols
- 12-C-0058 – A Phase II Study of Everolimus (RAD001) for Children with Neurofibromatosis Type-1 and Chemotherapy-Refractory Radiographic Progressive Low-Grade Gliomas
- 12-C-0136 – A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014